As previously reported in breast cancer cells [30], the rapid E2-dependent activation of the PI3K/AKT but not the ERK/MAPK pathway regulates Ser118 phosphorylation of ERα and its degradation, both events indicating the functional activation of the receptor [30,31,32]. The gene discussed is AKT1; the disease is breast cancer.